Liraglutide
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 78
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide 3.0 mg | Obesity or overweight | 3.0 mg | 96 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 96 | n/r | n/r |